Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-15-001428
Filing Date
2015-03-31
Accepted
2015-03-31 08:15:57
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT cbmg_10k.htm 10-K 2643649
2 CONSENT cbmg_ex231.htm EX-23.1 3300
3 CERTIFICATION cbmg_ex311.htm EX-31.1 19040
4 CERTIFICATION cbmg_ex312.htm EX-31.2 18985
5 CERTIFICATION cbmg_ex321.htm EX-32.1 9430
6 img01.jpg GRAPHIC 55025
  Complete submission text file 0001354488-15-001428.txt   8771498

Data Files

Seq Description Document Type Size
7 cmbg-20141231.xml EX-101.INS 1031118
8 cmbg-20141231.xsd EX-101.SCH 51640
9 cmbg-20141231_cal.xml EX-101.CAL 62387
10 cmbg-20141231_def.xml EX-101.DEF 125107
11 cmbg-20141231_lab.xml EX-101.LAB 391286
12 cmbg-20141231_pre.xml EX-101.PRE 288203
Mailing Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301
Business Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301 (650) 566-5064
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

EIN.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36498 | Film No.: 15736566
SIC: 2836 Biological Products, (No Diagnostic Substances)